Frequently Asked Questions
The market is segmented based on , By Type (Ataxia Cerebral Palsy, Athetoid Cerebral Palsy, Congenital Cerebral Palsy, Diplegia of Cerebral Palsy, Hemiparesis of Cerebral Palsy, Postnatal Cerebral Palsy, Spastic Cerebral Palsy and Others), Diagnosis (Imaging Tests, Laboratory Tests and Others), Treatment (Therapy, Medication and Surgery), Medical Devices (Orthotic Devices, ENT-Devices and Eye-Tracking Devices), Mobility Aids (Walkers, Walking Sticks and Canes, Crutches, Standers, Lifts, Wheelchairs, Power Scooters and Others), End User (Hospitals, Home Care, Physiotherapy Centres, Pathology Centres, Ambulatory, Speciality Clinics and Others) – Industry Trends and Forecast to 2030.
.
The Global Cerebral Palsy Market size was valued at USD 2618.74 USD Million in 2022.
The Global Cerebral Palsy Market is projected to grow at a CAGR of 6.2% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, Medtronic, Allergan, Boston Scientific Corporation, Johnson & Johnson, Pfizer , Novartis International AG, GSK plc., Teva Pharmaceutical Industries , Bayer AG, Ipsen, Acorda Therapeutics, Merck KGaA.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
